Employment and Quality of Life in Patients With Malignant Melanoma

Within the first year after diagnosis, data on employment and quality of life will be collected and evaluated in patients with malignant melanoma

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Malignant Melanoma of Skin Melanoma Neoplasms Neoplasms by Histologic Type Neoplasms by Site Neoplasms, Germ Cell and Embryonal Neoplasms, Nerve Tissue Neuroectodermal Tumors Neuroendocrine Tumors Nevi and Melanomas Quality of Life Skin Diseases Skin Neoplasms Skin and Connective Tissue Diseases Work Ability

Age range

18 year–65 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Fachklinik Hornheide

Münster, 48157, Germany

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

first diagnosis of malignant melanoma stage 0 to stage IIIC within the last 6 weeks
written informed consent

Exclusion criteria

diagnosis of malignant melanoma stage IV
inability to follow the protocol

Treatment and study plan

Quality of Life, status of employment

Behavioral

Primary outcomes

Quality of life questionnaire

Time frame: one year

Sponsors and collaborators

Lead sponsor

Fachklinik Hornheide an der Universität Münster

Other

Collaborators

Deutsche Rentenversicherung
Universität Münster

Registry information

Official study title

A Prospective Cohort Study on Employment and Quality of Life in Patients With Malignant Melanoma

Important dates

Study start: 2016
Primary completion: 2018
Study completion: 2019
First posted: Jan 29, 2016
Registry last updated: Feb 15, 2019

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Active, Not Recruiting